Alejandro Ocampo obtained his PhD in 2012 from the University of Miami for his work under the supervision of Antoni Barrientos on the role of mitochondria in neurodegenerative proteinopathies and aging. Between 2013 and 2017, he performed a post-doctoral training with Juan Carlos Izpisua-Belmonte at the Salk Institute for Biological Studies in La Jolla, California. During his post-doctoral training at the Salk, he developed a novel technology to prevent the transmission of mitochondrial diseases and demonstrated the amelioration of age-associated hallmarks by partial cellular reprogramming. In August 2018, he joined the Department of Pharmacology and Toxicology as Assistant Professor and will continue his work on aging, cellular reprogramming and mitochondrial diseases. His group conducts research in the areas of epigenetics, stem cells, aging and mitochondrial diseases with the goal of elucidating disease mechanisms and develop novel therapeutic approaches to improve the quality of life of patients.